國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Metabolic Diseases." ]

切換: 標籤 | MARC模式 | ISBD

Myotonic dystrophydisease mechanism,...

Matsumura, Tsuyoshi.

Myotonic dystrophydisease mechanism, current management and therapeutic development /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Myotonic dystrophyedited by Masanori P. Takahashi, Tsuyoshi Matsumura.
其他題名:	disease mechanism, current management and therapeutic development /
其他作者:	Takahashi, Masanori P.
出版者:	Singapore :Springer Singapore :2018.
面頁冊數:	viii, 214 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Myotonia atrophica.
電子資源:	https://doi.org/10.1007/978-981-13-0508-5
ISBN:	9789811305085$q(electronic bk.)

Myotonic dystrophydisease mechanism, current management and therapeutic development /
Myotonic dystrophydisease mechanism, current management and therapeutic development /[electronic resource] :edited by Masanori P. Takahashi, Tsuyoshi Matsumura. - Singapore :Springer Singapore :2018. - viii, 214 p. :ill., digital ;24 cm.

Genetics of myotonic dystrophy (including cDM and DM2) -- Basic Molecular pathomechanism -- Clinical features in skeletal muscle and their underlying molecular mechanism -- Clinical features in heart and their underlying molecular mechanism -- Clinical features of central nervous system -- Pathological changes in DM brain -- Molecular defect in DM central nervous system -- Respiratory feature in DM -- Glucose intolerance in DM -- Lipid metabolism in DM -- Dysphagia in DM -- DM patient-derived iPS cells -- Therapeutic development in DM.

This book provides an essential overview combining both clinical and fundamental research advances in myotonic dystrophy. The pathomechanism of myotonic dystrophy has long been unclear, but in the past decade, our understanding has shifted to a novel disease mechanism concept: "RNA disease". Parallel to these advances in elucidating the pathophysiology, translational research is also progressing rapidly. The current challenge lies in assessing the effectiveness of treatment, and as such, there is a growing interest in observational studies of the disease's various clinical symptoms. The book introduces readers to the molecular mechanisms within each organ and the resultant clinical features, which are presented together. In particular, it focuses on the central nervous system, since the pathology of the brain (central nervous system manifestation) has rarely been addressed systematically and will pose a persistent challenge, even if therapies have greatly advanced in the future. In addition, the book addresses the latest developments, such as research using patient-derived iPS cells and therapeutic research. Myotonic Dystrophy provides essential information for neurologists and researchers with an interest in muscle disease, including muscular dystrophy. Furthermore, since the disease involves various complications of the brain, heart, metabolism, etc., the book will be of great value to clinicians and researchers in the cardiovascular sciences, endocrinology, diabetes, dementia, and neuropsychology, as well as genetic specialists.

ISBN: 9789811305085$q(electronic bk.)

Standard No.: 10.1007/978-981-13-0508-5doiSubjects--Topical Terms:

825005
Myotonia atrophica.

LC Class. No.: RC935.M95 / M968 2018

Dewey Class. No.: 616.748

Myotonic dystrophydisease mechanism, current management and therapeutic development /
LDR:03128nmm a2200325 a 4500 001 545886
003 DE-He213
005 20190327102812.0
006 m d
007 cr nn 008maaau
008 190530s2018 si s 0 eng d
020 $a 9789811305085$q(electronic bk.)
020 $a 9789811305078$q(paper)
024 7 $a 10.1007/978-981-13-0508-5 $2 doi
035 $a 978-981-13-0508-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC935.M95 $b M968 2018
072 7 $a MJN $2 bicssc
072 7 $a MED056000 $2 bisacsh
072 7 $a MKJ $2 thema
082 0 4 $a 616.748 $2 23
090 $a RC935.M95 $b M997 2018
245 0 0 $a Myotonic dystrophy $h [electronic resource] : $b disease mechanism, current management and therapeutic development / $c edited by Masanori P. Takahashi, Tsuyoshi Matsumura.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a viii, 214 p. : $b ill., digital ; $c 24 cm.
505 0 $a Genetics of myotonic dystrophy (including cDM and DM2) -- Basic Molecular pathomechanism -- Clinical features in skeletal muscle and their underlying molecular mechanism -- Clinical features in heart and their underlying molecular mechanism -- Clinical features of central nervous system -- Pathological changes in DM brain -- Molecular defect in DM central nervous system -- Respiratory feature in DM -- Glucose intolerance in DM -- Lipid metabolism in DM -- Dysphagia in DM -- DM patient-derived iPS cells -- Therapeutic development in DM.
520 $a This book provides an essential overview combining both clinical and fundamental research advances in myotonic dystrophy. The pathomechanism of myotonic dystrophy has long been unclear, but in the past decade, our understanding has shifted to a novel disease mechanism concept: "RNA disease". Parallel to these advances in elucidating the pathophysiology, translational research is also progressing rapidly. The current challenge lies in assessing the effectiveness of treatment, and as such, there is a growing interest in observational studies of the disease's various clinical symptoms. The book introduces readers to the molecular mechanisms within each organ and the resultant clinical features, which are presented together. In particular, it focuses on the central nervous system, since the pathology of the brain (central nervous system manifestation) has rarely been addressed systematically and will pose a persistent challenge, even if therapies have greatly advanced in the future. In addition, the book addresses the latest developments, such as research using patient-derived iPS cells and therapeutic research. Myotonic Dystrophy provides essential information for neurologists and researchers with an interest in muscle disease, including muscular dystrophy. Furthermore, since the disease involves various complications of the brain, heart, metabolism, etc., the book will be of great value to clinicians and researchers in the cardiovascular sciences, endocrinology, diabetes, dementia, and neuropsychology, as well as genetic specialists.
650 0 $a Myotonia atrophica. $3 825005
650 1 4 $a Neurology. $3 211583
650 2 4 $a Cardiology. $3 273804
650 2 4 $a Metabolic Diseases. $3 274217
650 2 4 $a Human Genetics. $3 273658
700 1 $a Takahashi, Masanori P. $3 825003
700 1 $a Matsumura, Tsuyoshi. $3 825004
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-13-0508-5
950 $a Medicine (Springer-11650)